New Horizon Health IPO: Valuation Insights
New Horizon will raise gross proceeds of $244 million at the mid-point of the proposed IPO price range of HK$22.70-26.66. We would participate in...
1k Views
New Horizon Health IPO: PHIP Updates
New Horizon Health operates in the Chinese colorectal cancer screening market. The company has filed for an IPO on the HKEX and plans to raise...
299 Views
New Horizon Health IPO: Poised for Growth
New Horizon is set to launch a $300m HK IPO on Thursday. The PHIP which disclose the 9M20 results and the all-important NMPA approval for ColoClear...
303 Views
ECM Weekly (24 January 2021) - Kuaishou, New Horizon Health, Indigo Paints, Home First Fin, IRFC
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
373 Views
New Horizon Health (诺辉健康) Pre-IPO: Thoughts on Valuation
We value the company's core product, ColoClear at USD 2.6 bn and the company at USD 3.1bn on an SOTP basis. We will also discuss push factor that...
562 Views